Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.

Vaginal progesterone administration to women with a sonographic short cervix is an efficacious and safe intervention used to prevent preterm birth and neonatal morbidity and mortality. The clinical and public health implications of this approach in the United States have been critically appraised and compared to other therapeutic interventions in obstetrics. Vaginal progesterone administration to women with a transvaginal sonographic cervical length (CL) ≤25 mm before 25 weeks of gestation is associated with a significant and substantial reduction of the risk for preterm birth from <28 to <35 weeks of gestation, respiratory distress syndrome, composite neonatal morbidity and mortality, admission to the neonatal intensive care unit, and mechanical ventilation. These beneficial effects have been achieved in women with a singleton gestation, with or without a history of spontaneous preterm birth, and did not differ significantly as a function of CL (<10 mm, 10-20 mm, or 21-25 mm). The number of patients required for treatment to prevent 1 case of preterm birth or adverse neonatal outcomes ranges from 10-19 women. The number needed to screen for the prevention of 1 case of preterm birth before 34 weeks of gestation is 125 women, and 225 for the prevention of 1 case of major neonatal morbidity or neonatal mortality. Several cost-effectiveness and decision analyses have shown that the combination of universal transvaginal CL screening and vaginal progesterone administration to women with a short cervix is a cost-effective intervention that prevents preterm birth and associated perinatal morbidity and mortality. Universal assessment of CL and treatment with vaginal progesterone for singleton gestations in the United States would result in an annual reduction of approximately 30,000 preterm births before 34 weeks of gestation and of 17,500 cases of major neonatal morbidity or neonatal mortality. In summary, there is compelling evidence to recommend universal transvaginal CL screening at 18-24 weeks of gestation in women with a singleton gestation and to offer vaginal progesterone to those with a CL ≤25 mm, regardless of the history of spontaneous preterm birth, with the goal of preventing preterm birth and neonatal morbidity and mortality.

[1]  B. Mol,et al.  Cervical length measurement for the prediction of preterm birth in multiple pregnancies: a systematic review and bivariate meta‐analysis , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  P. Leppert,et al.  Progesterone protects fetal chorion and maternal decidua cells from calcium-induced death. , 2007, American journal of obstetrics and gynecology.

[3]  R. Romero,et al.  The preterm parturition syndrome , 2006, BJOG : an international journal of obstetrics and gynaecology.

[4]  K. Nicolaides,et al.  Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. , 2013, American journal of obstetrics and gynecology.

[5]  R. Romero,et al.  Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice. , 2013, American journal of obstetrics and gynecology.

[6]  S. Curtin,et al.  Births: final data for 2012. , 2013, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[7]  H. Wolfe,et al.  Patients with an ultrasonographic cervical length < or =15 mm have nearly a 50% risk of early spontaneous preterm delivery. , 2000, American journal of obstetrics and gynecology.

[8]  Christof Sohn,et al.  A novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor. , 2009, American journal of obstetrics and gynecology.

[9]  D. Haas,et al.  Progestogen for preventing miscarriage. , 2013, The Cochrane database of systematic reviews.

[10]  M. Elovitz,et al.  Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth? , 2007, American journal of obstetrics and gynecology.

[11]  Roberto Romero,et al.  Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[12]  J. Copel,et al.  Universal cervical‐length screening to prevent preterm birth: a cost‐effectiveness analysis , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[13]  A. Matias,et al.  Sonographic measurement of cervical length as a predictor of preterm delivery: a systematic review , 2014, Journal of perinatal medicine.

[14]  L. Keith,et al.  Precocious cervical ripening as a screening target to predict spontaneous preterm delivery among asymptomatic singleton pregnancies: a systematic review. , 2015, American journal of obstetrics and gynecology.

[15]  M. Hnat,et al.  Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. , 2007, Seminars in reproductive medicine.

[16]  L. Stewart,et al.  Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data , 2007, The Lancet.

[17]  R. Garfield,et al.  Loss of Progesterone Receptor-Mediated Actions Induce Preterm Cellular and Structural Remodeling of the Cervix and Premature Birth , 2013, PloS one.

[18]  V. Serra,et al.  Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double‐blind multicentre trial , 2013, BJOG : an international journal of obstetrics and gynaecology.

[19]  J. Kleijnen,et al.  Accuracy of cervical transvaginal sonography in predicting preterm birth: a systematic review. , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[20]  Roberto Romero,et al.  Prenatal medicine: The child is the father of the man* , 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[21]  R. Romero,et al.  Progesterone to prevent spontaneous preterm birth. , 2014, Seminars in fetal & neonatal medicine.

[22]  M. Elovitz,et al.  Inflammation promotes a cytokine response and disrupts the cervical epithelial barrier: a possible mechanism of premature cervical remodeling and preterm birth. , 2012, American journal of obstetrics and gynecology.

[23]  K. Orzechowski,et al.  Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update. , 2015, American journal of obstetrics and gynecology.

[24]  F. Naftolin,et al.  The Myometrium and Uterine Cervix in Normal and Preterm Labor , 1985 .

[25]  D. Wing,et al.  Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[26]  D. You,et al.  Levels and trends in child mortality : report 2013 , 2013 .

[27]  H. Honest,et al.  Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. , 2009, Health technology assessment.

[28]  A. Badawy,et al.  Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety , 2015, Archives of Gynecology and Obstetrics.

[29]  R. Wapner,et al.  Cervical ultrasonography compared with manual examination as a predictor of preterm delivery. , 1997, American journal of obstetrics and gynecology.

[30]  C. Combs Vaginal progesterone for asymptomatic cervical shortening and the case for universal screening of cervical length. , 2012, American journal of obstetrics and gynecology.

[31]  R. Romero,et al.  A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix , 2013, Journal of perinatal medicine.

[32]  K. Nicolaides,et al.  Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta‐analysis , 2015, BJOG : an international journal of obstetrics and gynaecology.

[33]  O. Clark,et al.  Cervical Assessment With Progesterone in the Prevention of Preterm Birth: A Strategy Based On Cost-Effectiveness. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[34]  A. Murtha,et al.  Characterization of progesterone receptor isoform expression in fetal membranes. , 2005, American journal of obstetrics and gynecology.

[35]  J. Weeks,et al.  Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double‐blind, placebo‐controlled trial , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[36]  A. Gülmezoglu,et al.  Anticonvulsants for women with pre-eclampsia. , 2000, The Cochrane database of systematic reviews.

[37]  Stephanie Schrag,et al.  Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC , 2002 .

[38]  J. Emerson,et al.  126: The impact of cervical length on the cost-effectiveness of vaginal progesterone as a preterm birth intervention , 2012 .

[39]  R. Romero,et al.  Prediction of preterm birth in twin gestations using biophysical and biochemical tests. , 2014, American journal of obstetrics and gynecology.

[40]  R. Romero,et al.  Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. , 2009, American journal of obstetrics and gynecology.

[41]  R. Romero,et al.  Predictive accuracy of changes in transvaginal sonographic cervical length over time for preterm birth: a systematic review and metaanalysis. , 2015, American journal of obstetrics and gynecology.

[42]  M. Elovitz,et al.  Prevention of preterm birth by progestational agents: what are the molecular mechanisms? , 2013, American journal of obstetrics and gynecology.

[43]  V. Berghella Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. , 2012, American journal of obstetrics and gynecology.

[44]  D. Roberts,et al.  Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. , 2012, The Cochrane database of systematic reviews.

[45]  K. Nicolaides,et al.  Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. , 2012, American journal of obstetrics and gynecology.

[46]  R. Romero Progesterone to prevent preterm birth in twin gestations: what is the next step forward? , 2013, BJOG : an international journal of obstetrics and gynaecology.

[47]  R. Romero,et al.  Is 17α‐hydroxyprogesterone caproate contraindicated in twin gestations? , 2015, BJOG : an international journal of obstetrics and gynaecology.

[48]  G. C. Renzo The Great Obstetrical Syndromes , 2009 .

[49]  S. Fisher,et al.  Preterm labor: One syndrome, many causes , 2014, Science.

[50]  J. Crane,et al.  Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[51]  B. Blondel,et al.  [The length of the cervix and the risk of spontaneous premature delivery]. , 1996, Revue d'epidemiologie et de sante publique.

[52]  R. Romero,et al.  Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor. , 2013, Journal of reproductive immunology.

[53]  A. Caughey,et al.  Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. , 2010, American journal of obstetrics and gynecology.

[54]  Roberto Romero,et al.  Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface. , 2015, American journal of obstetrics and gynecology.

[55]  MD PhD Ahizechukwu Eke,et al.  756: Vaginal progesterone versus cervical cerclage for the prevention of preterm births in women with a sonographically short cervix–a cost effectiveness and decision analysis , 2015, American Journal of Obstetrics and Gynecology.

[56]  J. Steichen,et al.  490: Two year infant outcomes for children exposed to supplemental intravaginal progesterone gel in utero: secondary analysis of a multicenter, randomized, double-blind, placebo-controlled trial , 2011 .

[57]  S. Yellon,et al.  Progesterone Withdrawal Promotes Remodeling Processes in the Nonpregnant Mouse Cervix1 , 2009, Biology of reproduction.

[58]  S. Yellon,et al.  Remodeling of the Cervix and Parturition in Mice Lacking the Progesterone Receptor B Isoform1 , 2011, Biology of reproduction.

[59]  A. Ohlsson,et al.  Intrapartum antibiotics for known maternal Group B streptococcal colonization. , 2013, The Cochrane database of systematic reviews.

[60]  E. Mozurkewich,et al.  397: Cost analysis of universal cervical length screening and progesterone therapy in remote populations , 2014 .

[61]  J. Dungan Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length , 2010 .

[62]  A. Fayed,et al.  Progestogen for treating threatened miscarriage. , 2018, The Cochrane database of systematic reviews.

[63]  L. Sullivan,et al.  Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double‐blind, placebo‐controlled trial , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[64]  M. Terplan,et al.  Transvaginal Ultrasonographic Measurement of Cervical Length as a Predictor of Preterm Birth: A Systematic Review With Meta-Analysis , 2010, Ultrasound quarterly.

[65]  K. Matsushima,et al.  Suppression of interleukin 8 production by progesterone in rabbit uterine cervix. , 1994, The Biochemical journal.

[66]  I. Green Cervical remodeling in term and preterm birth: insights from an animal model , 2012 .

[67]  G. Gyte,et al.  Active versus expectant management for women in the third stage of labour. , 2010, The Cochrane database of systematic reviews.

[68]  Julie Gilchrist,et al.  "Choking game" awareness and participation among 8th graders--Oregon, 2008. , 2010, MMWR. Morbidity and mortality weekly report.

[69]  M. Sakalli,et al.  Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial , 2011, Archives of Gynecology and Obstetrics.

[70]  Julie Brown,et al.  Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.

[71]  B. Sibai,et al.  Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. , 2001, JAMA.

[72]  S. Curtin,et al.  Births: final data for 2013. , 2015, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[73]  K. Nicolaides,et al.  Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo‐controlled trial on the effect of vaginal micronized progesterone , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[74]  K. Nicolaides,et al.  Progesterone and the risk of preterm birth among women with a short cervix. , 2007, The New England journal of medicine.

[75]  R. Garfield,et al.  Regulation of the Uterus and Cervix during Pregnancy and Labor Role of Progesterone and Nitric Oxide , 1997, Annals of the New York Academy of Sciences.

[76]  Gynecologists Practice bulletin no. 130: prediction and prevention of preterm birth. , 2012, Obstetrics and gynecology.

[77]  K. Nicolaides,et al.  Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[78]  L. Pizzi,et al.  Cost and Cost Effectiveness of Vaginal Progesterone Gel in Reducing Preterm Birth: An Economic Analysis of the PREGNANT Trial , 2014, PharmacoEconomics.

[79]  R. Romero,et al.  Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis. , 2010, American journal of obstetrics and gynecology.

[80]  R. Romero,et al.  Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice. , 2011, The American journal of pathology.